Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation.
Saved in:
| Title: | Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation. |
|---|---|
| Authors: | Pistolesi A; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy., De Cesaris F; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy., Buonvicino D; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy. Electronic address: daniela.buonvicino@unifi.it., Chiarugi A; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy. |
| Source: | The journal of pain [J Pain] 2025 Aug; Vol. 33, pp. 105456. Date of Electronic Publication: 2025 Jun 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Churchill Livingstone Country of Publication: United States NLM ID: 100898657 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-8447 (Electronic) Linking ISSN: 15265900 NLM ISO Abbreviation: J Pain Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1528-8447 |
|---|---|
| DOI: | 10.1016/j.jpain.2025.105456 |
